Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Evaluating a primary care pharmacist-led intervention to reduce opioid use for persistent non-cancer pain: the PROMPPT cluster randomised controlled trial protocol 2026-10-29
  2. Heat-related mortality by comorbidity and cause of death: a time-stratified case-crossover study of 3.7 million deaths in Brazil, 2014–2025 2026-10-22
  3. Feature harmonization reveals that apparent cross-cohort differences in tau-positivity prediction reflect variable availability and cohort stage structure 2026-10-21

Studies

109 studies carry this tag.

Date range

1964 to 2026

Top journals

  • PubMed 7
  • medRxiv 6
  • Annals of Internal Medicine 5
  • Lancet (London, England) 5
  • National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 5

74 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The PROMPPT trial will assess whether review by trained clinical pharmacists working in general practices can support safe opioid reduction without compromising pain management and quality of life.

  2. Heat-related mortality by comorbidity and cause of death: a time-stratified case-crossover study of 3.7 million deaths in Brazil, 2014–2025

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-10-22 Risk factors

    Because deaths without a given condition differ in cause composition from deaths with it, each condition was also compared with deaths carrying another of the studied conditions: the dementia estimate strengthened to 1.050 (1.036–1.065), and cerebrovascular disease reached 1.018 (1.009–1.027), a smaller but statistically robust positive modification.

  3. Feature harmonization reveals that apparent cross-cohort differences in tau-positivity prediction reflect variable availability and cohort stage structure

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-10-21 Genetics

    In the primary matched-feature comparison, reference areas under the receiver operating characteristic curve (AUCs) were 0.851 for ADNI tau90, 0.860 for ADNI tau180, and 0.933 for OASIS3 tau180.

  4. Electronic Health Record-Based Machine Learning Models for Predicting Revascularization, Amputation, and Cardiovascular Mortality in At-Risk Patients

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-10-11 Digital health tools

    Patients with peripheral artery disease (PAD), chronic limb-threatening ischemia (CLTI), and/or diabetic foot ulcer (DFU) are at increased risk for limb loss and death.

  5. Seasonally Normalized Vitamin D Status and Long-Term Mortality and Multisystem Disease Risk in the UK Biobank

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-10-09 Risk factors

    Seasonally normalized 25(OH)D identifies a reproducible state of systemic vulnerability while reducing exposure misclassification caused by calendar timing of measurement.

  6. How Much Non-response Matters? Diagnosis Prevalence Estimates in Survey Participants Versus the Total Sample

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-08-25 Costs and economics

    In this setting, selective participation had only a limited effect on prevalence estimates after weighting.

  7. Seven routine blood markers predict five-year mortality in older Indians: a risk score from the LASI-DAD cohort

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-07-09 End-of-life care

    Among 2144 participants (540 deaths over a median 4.4 years of survivor follow-up; 25% mortality), the seven-marker score plus age and sex achieved an apparent C of 0.74 (optimism-corrected 0.74), versus 0.68 for age and sex alone (Δ ≈ 0.06); the blood panel alone reached C 0.72.

  8. Understanding end-of-life multimorbidity: An analysis of multiple causes of death in Denmark

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-07-07 End-of-life care

    We examined how often each diagnosed disease appeared on the certificate, its location and selection as the UCD, factors associated with its appearance (logistic regression), disease-specific mortality (multiple decrement life tables), and disease associations (Cause of Death Association Indicator, CDAI).

  9. Clinical Efficacy of Comprehensive Geriatric Assessment in Patients Undergoing Hemodialysis: A Retrospective Observational Study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Preprints.org 2026-07-06 Health systems and care delivery

    Functional decline, as assessed by CGA, was more prominent in patients undergoing hemodialysis than in those not undergoing hemodialysis.

  10. Gaps in Vascular Evaluation Before Major Lower-Extremity Amputation Among Medicare Beneficiaries With Chronic Limb-Threatening Ischemia

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-04-28 Costs and economics

    Among 10,666 patients (mean age 76.6 years; 35% female; 70% White, 21% Black), phenotype distribution was: A, 9.4%; B, 7.1%; C, 50.7%; D, 32.7%.

  11. A multidomain intrinsic capacity score tracks longitudinal health trajectories in the UK Biobank

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-04-13 Risk factors

    Quantitative measures for tracking functional health have generally been lacking.

  12. Comparison of quality of sepsis care among patients with vs. without acute mental health crises

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-02-11 Clinical safety

    Previous research has shown patients with mental health issues receive worse quality of diabetes and cardiac care and have poorer outcomes compared with those without mental health issues.

  13. Longitudinal Pain Management Patterns and Risk of Adverse Outcomes in Older Adults: Insights from Group-Based Multi-Trajectory Modeling

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Authorea Preprints 2024-12-28 Costs and economics

    These findings highlight that extensive long-term utilization of pain management strategies in older adults is associated with increased risks of adverse outcomes, particularly hospitalizations and incident dementia, especially among fit older adults, emphasizing the need for careful monitoring and personalized approaches to pain management in older populations, balancing effective pain control with minimization of potential long-term risks.

  14. Updated information on the Diagnosis Procedure Combination data

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Annals of clinical epidemiology 2024-09-04 Digital health tools

    The Ministry of Health, Labor, and Welfare, Japan, launched the Diagnosis Procedure Combination system in 2002.

  15. Inadequate insurance coverage for overweight/obesity management

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. The American journal of managed care 2024-08 Disparities

    Obesity is a significant health crisis affecting more than 123 million adults and children/adolescents in the US.

  16. Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. The journal of prevention of Alzheimer's disease 2024-01-01 Treatments

    The mean age was 72 years (49-90 years), and 44 (62%) patients were female.

  17. These three main clusers were confirmed in a testing sample.

  18. Chronic Pain Among Adults - United States, 2019-2021

    ⚠ Report — not peer-reviewed alzhub usefulness score 16 out of 100. MMWR. Morbidity and mortality weekly report 2023-04-14 Risk factors

    Chronic pain (i.e., pain lasting ≥3 months) is a debilitating condition that affects daily work and life activities for many adults in the United States and has been linked with depression (1), Alzheimer disease and related dementias (2), higher suicide risk (3), and substance use and misuse (4).

  19. Racial/Ethnic Differences in Risk Factors Associated With Severe COVID-19 Among Older Adults With ADRD

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Journal of the American Medical Directors Association 2023-03-09 Disparities

    We found higher risks of COVID-19-related outcomes among Black and Hispanic individuals.

  20. Comparing ARIA-E severity scales and effects of treatment management thresholds

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2022-12-02 Treatments

    SSAE-3/5 scores correlated with BGTS scores, with high inter-reader intraclass correlation coefficients across all scales.

  21. Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990–2019

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in Public Health 2022-11-29 Prevention and risk

    Globally, in 2019, there were nearly 10 million deaths and 349 million DALYs due to neurological disorders.

  22. Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. EP Europace 2022-08-24 Cognitive tests and assessment

    Atrial fibrillation (AF) is the most common clinical arrhythmia with substantial health and socioeconomic impact on healthcare.1 The number of people affected by this condition was estimated to be 33.5 million in 2010, with an increasing prevalence and incidence over the coming years.2 In 2017, there were 37.6 million [95% confidence interval (CI): 32.5–42.6 million] individuals with AF/atrial flutter globally.3 The estimated number of subjects with AF in 2030 in Europe will be 14–17 million, and the number of new cases of AF per year at 120 000–215 000.4 Atrial fibrillation is independently associated with increased mortality and morbidity from complications such as ischaemic stroke, dementia, and cognitive dysfunction.5 Oral anticoagulation can significantly reduce the risk of stroke, dementia, and death.6 As a part of a holistic or integrated approach to AF care, it is associated with improved outcomes7–9 and is advocated in guidelines.10,11 In many patients, AF can be asymptomatic, and the diagnosis is established after the appearance of a complication typically associated with AF, such as ischaemic stroke/systemic embolic or heart failure.

  23. Equitability of Depression Screening After Implementation of General Adult Screening in Primary Care

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. JAMA network open 2022-08-01 Digital health tools

    Men, racial and ethnic minority individuals, older adults, and those with language barriers are at increased risk for undertreatment of depression.

  24. Cohort Profile Update: The Study of Health in Pomerania (SHIP)

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. International Journal of Epidemiology 2022-02-25 Drug development

    Therefore, respective software was developed in-house.8,9 Segmentation results are then analysed for potential associations with disease risks and to establish reference intervals of organ size and function.10 SHIP is also used as a basis for meta-research with a particular focus on incidental MRI findings and their effects on study participants.11,12 With its large amount of standardized data and the option to internally replicate findings from SHIP-START using data of the independent SHIP-TREND, the project offers good opportunities to apply new bioinformatical tools to mine the data and gain new insights into risk factors and pathomechanisms.

  25. National General Health Screening Program in Korea: history, current status, and future direction

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Precision and Future Medicine 2022-02-23 Disparities

    Health screening is an important component of health promotion programs, and countries have promoted general health screening targeting the prevention and early management of common chronic diseases.

  26. Cohort Profile: The Longitudinal Ageing Study in India (LASI)

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. International Journal of Epidemiology 2021-12-13 Costs and economics

    LASI is India’s first ageing study and the world’s largest in terms of sample size, and will provide comprehensive longitudinal data for designing policies and programmes targeted toward the overall well-being of the older population.

  27. Social isolation, social support and loneliness as predictors of cardiovascular disease incidence and mortality

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. BMC geriatrics 2021-12-13 Risk factors

    Individuals with poor social health were 42 % more likely to develop CVD (p = 0.01) and twice as likely to die from CVD (p = 0.02) over a median 4.5 years follow-up.

  28. Low-Value Care at the Actionable Level of Individual Health Systems

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. JAMA internal medicine 2021-11-01 Digital health tools

    The findings of this large cohort study suggest that system-level measurement and reporting of specific low-value services is feasible, enables cross-system comparisons, and reveals a broad range of low-value care use.

  29. Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Annals of internal medicine 2021-10-05 Disparities

    An estimated 2.88 million deaths occurred between March and December 2020.

  30. Specifically, periodontal disease has been associated with diabetes, metabolic syndrome, obesity, eating disorders, liver disease, cardiovascular disease, Alzheimer disease, rheumatoid arthritis, adverse pregnancy outcomes, and cancer.

  31. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. The Lancet. Infectious diseases 2021-09-01 Risk factors

    This prospective, community-based, nested, case-control study used self-reported data (eg, on demographics, geographical location, health risk factors, and COVID-19 test results, symptoms, and vaccinations) from UK-based, adult (≥18 years) users of the COVID Symptom Study mobile phone app.

  32. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. The Lancet. Child & adolescent health 2021-08-03 Digital health tools

    Illness duration and symptom prevalence, duration, and burden were analysed for children testing positive for SARS-CoV-2 for whom illness duration could be determined, and were assessed overall and for younger (age 5-11 years) and older (age 12-17 years) groups.

  33. Obesity, Vascular Disease and Frailty in Aging Women with HIV

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Advances in geriatric medicine and research 2021-06-22 Risk factors

    Women with chronic HIV infection (WWH) living in the United States, experience a disproportionately high rate of obesity compared to uninfected populations.

  34. Impact of the COVID-19 Pandemic on Older Adults: Rapid Review

    ✓ Peer-reviewed alzhub usefulness score 83 out of 100. JMIR aging 2021-04-12 Prevention trials

    Our results highlight the need for adequate isolation and protective measures.

  35. Cuba's cardiovascular risk factors: International comparison of levels and education gradients

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. PloS one 2021-03-04 Risk factors

    Neither medically amenable nor behavioral risk factors are uniformly better in Cuba than comparison countries.

  36. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

    ✓ Peer-reviewed alzhub usefulness score 86 out of 100. Annals of Internal Medicine 2020-11-11 Risk factors

    Of 1648 patients with COVID-19 admitted to 38 hospitals, 398 (24.2%) died during hospitalization and 1250 (75.8%) survived.

  37. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. The Lancet. Public health 2020-07-31 Cognitive tests and assessment

    We sought to assess risk of COVID-19 among front-line health-care workers compared with the general community and the effect of personal protective equipment (PPE) on risk.

  38. Japanese Clinical Practice Guideline for Diabetes 2019

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Journal of Diabetes Investigation 2020-07-01 Drug development

    Of note, dramatic progress has been made in recent years in diabetes research and clinical practice, which includes approval of antidiabetic agents with novel mechanisms of action along with publication of clinical trial results with these drugs, and novel diagnostic and therapeutic devices, such as continuous glucose monitoring (CGM) and sensor augmented pumps (SAP).

  39. Technology Literacy as a Barrier to Telehealth During COVID-19

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Telemedicine Journal and e-Health 2020-05-19 Cognitive tests and assessment

    Prior work has shown that the video component significantly contributes to quality and satisfaction of the visit.3 In addition to the technology itself, patients need to know what to expect for their telehealth appointments.

  40. US Health Care Spending by Payer and Health Condition, 1996-2016

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. JAMA 2020-03-01 Risk factors

    Total health care spending increased from an estimated $1.4 trillion in 1996 (13.3% of gross domestic product [GDP]; $5259 per person) to an estimated $3.1 trillion in 2016 (17.9% of GDP; $9655 per person); 85.2% of that spending was included in this study.

  41. Changes in the Place of Death in the United States

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. New England Journal of Medicine 2019-12-11 End-of-life care

    n d e n c e Changes in the Place of Death in the United States To the Editor: Where people die is an impor tant determinant of patient and caregiver expe rience.

  42. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Nephrology Dialysis Transplantation 2019-07-29 Risk factors

    As a result, kidney disease has been largely overlooked by health authorities and governments in most countries [9].

  43. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Lancet (London, England) 2019-06-24 Risk factors

    We compared the observed results with expected values estimated based on the Socio-demographic Index (SDI).

  44. Deaths: Leading Causes for 2017

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 2019-06-01 Disparities

    In 2017, the 10 leading causes of death were, in rank order: Diseases of heart; Malignant neoplasms; Accidents (unintentional injuries); Chronic lower respiratory diseases; Cerebrovascular diseases; Alzheimer disease; Diabetes mellitus; Influenza and pneumonia; Nephritis, nephrotic syndrome and nephrosis; and Intentional self-harm (suicide).

  45. Risk Factor Variability and Cardiovascular Outcome: JACC Review Topic of the Week

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Journal of the American College of Cardiology 2019-05-28 Risk factors

    Until recently, intraindividual visit-to-visit variability of cardiovascular risk factors has been dismissed as random fluctuation.

  46. Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Digestive diseases and sciences 2018-11-28 Digital health tools

    In this large population-based study, the overall prevalence of Whipple's disease in the USA is 9.8 cases per 1 million people.

  47. The global burden of multiple chronic conditions: A narrative review

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Preventive medicine reports 2018-10-19 Risk factors

    Globally, approximately one in three of all adults suffer from multiple chronic conditions (MCCs).

  48. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

    ✓ Peer-reviewed alzhub usefulness score 79 out of 100. The New England journal of medicine 2018-09-16 How common it is

    Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death.

  49. Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Pharmacotherapy 2018-09-04 Digital health tools

    Study objective To examine the risks and compare the occurrences of major long-term side effects (sexual dysfunction, bone fractures, diabetes, cardiovascular morbidity, acute myocardial infarction [MI], and dementia) in patients with prostate cancer who received androgen-deprivation therapy (ADT) with those who did not.

  50. Prevalence and Costs of Discharge Diagnoses in Inpatient General Internal Medicine: a Multi-center Cross-sectional Study

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Journal of general internal medicine 2018-07-27 Digital health tools

    GIM services care for a markedly heterogeneous population but the most common conditions were similar across 7 hospitals.

From across this tag

6 of the 109 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 6. The same 6 appear here every time.

All topic tags with their study counts